revenue

Posted by taipan @taipan, Jun 5 6:02am

revenue in 2024 is approximately $57.75 billion. This includes ~$22.5 billion from COPD therapeutics, ~$18.25 billion from inhalers and nebulizers, and ~$17 billion from oxygen therapy devices.
we are feeding the industry l!!

Interested in more discussions like this? Go to the COPD: Chronic obstructive pulmonary disease Support Group.

taipan | @taipan | Jun 5 6:04am

would be nice to see some curing soon or does this hurt the pockets too much...

crystalena | @crystalena | Jun 5 9:06am

I don’t think they are trying to improve the treatments . A cure maybe not . A stabilization ? Why not?. I would like them to just be able to stop COPD from completely destroying the lungs . Big pharma , Medicare, Medical Hospital Associations, Are probably happy with the numbers. We do not get the correct numbers from our advantage plans . We can choose from a few different plans , and maybe pick one better for our circumstances. They are all fictitious number games . I wonder sometimes if inhalers are even effective in my case . I did not report symptoms or have any medication for Emphysema until I was stage 4. They gave me an inhaler . Kept asking me if it helped. I still cannot say I know it helps . Do I need it ? I am not sure anymore . Blessed Be, Crystalena